FOR IMMEDIATE RELEASE
SCIENTIFIC LEADERS IN NEUROLOGICAL INFECTIONS ADDRESS SHORT AND LONG TERM COVID-19 IMPLICATIONS AT ASENT 2021 ANNUAL MEETING
Speakers from NINDS, Yale and University of Gothenburg discuss research in acute and chronic neurological implications of COVID-19
February 3, 2021 — The Kathleen Clarence-Smith and Thomas Chase Keynote Lecture and Presidential Symposium will kick off the ASENT 2021 Annual Meeting and will bring together three leading clinician-scientists from the United States and Sweden to discuss the neurologic implications of COVID-19. The American Society for Experimental Neurotherapeutics (ASENT) virtual annual meeting opens on February 22, 2021 and runs through February 25, 2021. The Presidential Symposium will cover neurological consequences of viral pandemics, including COVID-19; neurological impact during acute COVID-19; and neurologic symptoms post-acute COVID-19.
“We are grateful to have this extraordinary faculty contribute to what promises to be an outstanding session at the ASENT 2021 virtual annual meeting. The pandemic numbers are staggering and opening the ASENT meeting with a session on COVID-19 is extremely timely. We are honored to have the opportunity to share the new and evolving research targeting how COVID-19 is impacting the nervous system,” noted Tom Sutula, MD, PhD, Professor Emeritus, University of Wisconsin, Madison, and President of the ASENT.
The faculty will answer questions from attendees during a live panel discussion following their scientific presentations. They will discuss leading-edge research relevant to the neurology and neuroscience communities as well as the critical care, emergency medicine, family medicine, nursing, and extended care practitioners. The faculty are:
- Avindra Nath, MD, Chief of the Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, will discuss COVID-19 in the context of prior pandemics; mechanisms of infection and disease—specifically CNS infection versus peripheral infection; and what NIH and researchers are learning from post-mortem evidence.
Kathleen Clarence-Smith and Thomas Chase Keynote Lecture
PRESENTATION: Neurological Consequences of Viral Pandemics including COVID-19
- Arvid Edén, MD, PhD, Senior consultant, Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden, will discuss the mechanisms of COVID-19 infection and provide an overview of acute CNS presentations, including anosmia, encephalopathy, and stroke.
PRESENTATION: Neurological impact during acute COVID-19 – marked CNS immune activation but no clear evidence of viral invasion
- Serena S. Spudich, MD, Gilbert H. Glaser Professor of Neurology and Chief, Division of Neurological Infections and Global Neurology at Yale University, will discuss the long term complications of COVID-19 including post-COVID clinical syndromes that are appearing, including cognitive and autonomic, as well as small fiber neuropathies, headache, and mood disorders. Dr. Spudich will also present future directions–diagnosis; predictive markers; treatment—as well as predictors of efficacy.
PRESENTATION: The Long Goodbye: Understanding Neurologic Symptoms Post-Acute COVID-19
“ASENT is honored to feature these three international medical experts from whom we will learn about the short and long-term causes and neurological complications of COVID-19”, remarked C. Anthony Altar, PhD, Co-Chair of the ASENT program committee.
History of Keynote
The ASENT Annual Meeting keynote lecture is named in honor of two of ASENT’s founders: Kathleen (“Kitty”) Clarence-Smith, MD, PhD, and husband, Thomas Chase, SB, MD, internationally-recognized neurologists each with 40 years of experience in the discovery and clinical development of new drugs for central nervous system diseases.
ASENT 2021 Annual Meeting
Registration to attend the full ASENT 2021 Annual Meeting is free and takes place in a virtual format February 22-25, 2021. It features scientific symposia, poster sessions, pipeline sessions, and online networking. Topics also include: Obstacles and Opportunities in Alzheimer’s Disease Neurotherapeutics; RNA editing and CRISPR: basic approaches and treatment implications for neurologic disease; New and Emerging Therapeutics for Epilepsy; Dystonia: Genetics, pathophysiology, new targets and treatment; Epigenetics in Neurodegenerative Disorders; Emerging therapeutics in NeuroOncology; Brain Organoids as Models of Neurological Disorders and Treatment; and Parkinson’s Disease: New Approaches..
For more information on the ASENT 2021 Annual Meeting visit: http://bit.ly/ASENTAM2021
The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. The organization’s primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
Microvascular Injury in the Brains of Patients with Covid-19 Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H, Dodd SJ, Koretsky AP, Watts JA, Cheung V, Masliah E, Horkayne-Szakaly I, Jones R, Stram MN, Moncur J, Hefti M, Folkerth RD, Nath A. New England Journal of Medicine, Dec 29, 2020.
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Abrams RPM, Yasgar A, Teramoto T, Lee MH, Dorjsuren D, Eastman RT, Malik N, Zakharov AV, Li W, Bachani M, Brimacombe K, Steiner JP, Hall MD, Balasubramanian A, Jadhav A, Padmanabhan R, Simeonov A, Nath A. Proc Natl Acad Sci. 2020 Dec 8;117(49):31365-31375.
A Longitudinal Study of Ebola Sequelae in Liberia Sneller MC, Reilly C, Badio M, Bishop RJ, Eghrari AO, Moses SJ, Johnson KL, Dehkontee G-D, Hensley LE, Higgs ES, Nath A, Tuznik K, Varughese J, Jensen KS, Dighero-Kemp, B, Neaton JD, Lane HC, Fallah MP. New England Journal of Medicine, 2019 Mar 7;380(10):924-934.
Neurologic Complications of Coronavirus Infections. Nath A. Neurology, (March 30, 2020)
Long-Haul COVID Nath A. Neurology (Editorial). Oct 2020
Lessons from a neurology consult service for patients with COVID-19. McAlpine LS, Zubair AS, Moeller J, Baehring J, Spudich S. Lancet Neurol. 2020 Oct;19(10):806-807. doi: 10.1016/S1474-4422(20)30316-1. Epub 2020 Sep 16. PMID: 32949536 Free PMC article.
Assessment of Brain Injury Using Portable, Low-Field Magnetic Resonance Imaging at the Bedside of Critically Ill Patients. Sheth KN, Mazurek MH, Yuen MM, Cahn BA, Shah JT, Ward A, Kim JA, Gilmore EJ, Falcone GJ, Petersen N, Gobeske KT, Kaddouh F, Hwang DY, Schindler J, Sansing L, Matouk C, Rothberg J, Sze G, Siner J, Rosen MS, Spudich S, Kimberly WT. JAMA Neurol. 2020 Sep 8:e203263. doi: 10.1001/jamaneurol.2020.3263. Online ahead of print.
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, Zhou J, Odio C, Vijayakumar P, Geng B, Fournier J, Bermejo S, Fauver JR, Alpert T, Wyllie AL, Turcotte C, Steinle M, Paczkowski P, Dela Cruz C, Wilen C, Ko AI, MacKay S, Grubaugh ND, Spudich S, Barakat LA. BMC Neurol. 2020 Jun 18;20(1):248. doi: 10.1186/s12883-020-01812-2. PMID: 32552792 Free PMC article.
Coronavirus disease 2019 and neurodegenerative disease: what will the future bring? McAlpine LS, Fesharaki-Zadeh A, Spudich S. Curr Opin Psychiatry. 2020 Dec 31;Publish Ahead of Print.
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. JAMA Neurol. 2020 Aug 1;77(8):1018-1027. doi: 10.1001/jamaneurol.2020.2065. PMID: 32469387 Free PMC article.